Noticias de ONCY_US

Noticias del mercado

Últimas noticias sobre ONCY_US — 69 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ONCY_US ✕ 69 resultados
13/03/2026 ONCY_US — GuruFocus ES ← EN
Compra de información privilegiada: James Parsons adquiere acciones adicionales de Onco
05/03/2026 ONCY_US — PR Newswire
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
03/03/2026 ONCY_US — Oncodaily
Oncolytics Biotech Launches Randomized Phase 2 REO-033 Trial for Pelareorep in RAS-Mutant MSS Metastatic Colorectal Cancer — With FDA Fast Track Behind It
03/03/2026 ONCY_US — PR Newswire
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
02/03/2026 ONCY_US — GlobeNewswire
Oncolytics Biotech® Launches Randomized Colorectal Cancer Study
02/03/2026 ONCY_US — Stock Titan
Colorectal cancer trial to test new immunotherapy after chemo fails
02/03/2026 ONCY_US — GlobeNewswire
Oncolytics Biotech® Launches Randomized Colorectal Cancer Study
02/03/2026 ONCY_US — Stock Titan
Oncolytics Biotech (NASDAQ: ONCY) launches Phase 2 pelareorep colorectal cancer study
25/02/2026 ONCY_US — PR Newswire
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
24/02/2026 ONCY_US — Stock Titan ES ← EN
Oncolytics traza un ensayo con menos de 100 pacientes que busca la aprobación de la FDA en cáncer anal raro
24/02/2026 ONCY_US — Yahoo Finance
Oncolytics Biotech® to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer
24/02/2026 ONCY_US — BioSpace
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
24/02/2026 ONCY_US — Seeking Alpha
Oncolytics to stop enrollments for GIT cancer trial (ONCY)
24/02/2026 ONCY_US — GuruFocus
Oncolytics (ONCY) Completes Enrollment in GOBLET Study, Advances Cancer Research
24/02/2026 ONCY_US — GuruFocus
Oncolytics Biotech (ONCY) Ends Enrollment in GOBLET Study to Foc
17/02/2026 ONCY_US — PR Newswire
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
05/02/2026 ONCY_US — BioSpace
$207B Market Shift: The Race for Fast Track Approval in Oncology
05/02/2026 ONCY_US — Newswire Canada ES ← EN
Cambio de mercado de 207.000 millones de dólares: la carrera por la aprobación rápida en oncología
05/02/2026 ONCY_US — GlobeNewswire
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
04/02/2026 ONCY_US — GlobeNewswire
Oncolytics Biotech® Receives FDA Fast Track Designation for

Página 3 de 4

keyboard_arrow_up